Pharmaceutical giant Eli Lilly and Co. is reportedly considering leaving Indiana as the Hoosier state has decided to go forward with more abortion restrictions.
Lilly recognizes that abortion is a divisive and deeply personal issue with no clear consensus among the citizens of Indiana, the company said in a statement Saturday. Despite this lack of agreement, Indiana has opted to quickly adopt one of the most restrictive anti-abortion laws in the United States.
Given Eli Lillys statement, you might think Indianas new abortion ban would be one of the toughest in the country, in line with other states like South Carolina, which is considering a near-total ban with exceptions only if the life of the mother is in danger. But Indianas new abortion ban thats slated to take effect on Sept. 15 only restricts abortions after ten weeks. It includes carve outs to protect the life of the mother, and continues to allow abortions in the case of rape and incest. The Indiana legislature, however, decided not to go forward with a provision that would require women who get abortions under the rape and incest exemptions to sign a notarized affidavit of their claim.
Indianas new pro-life law would also require that abortions be performed in hospitals or outpatient centers owned by hospitals, which means all abortion clinics will lose their licenses and, thankfully, be forced out of the state. Doctors who perform illegal abortions or fail to file proper reports about the procedure will also lose their medical licenses.
"We are concerned that this law will hinder Lilly's and Indiana's ability to attract diverse scientific, engineering and business talent from around the world, Eli Lillys statement continued. While we have expanded our employee health plan coverage to include travel for reproductive services unavailable locally, that may not be enough for some current and potential employees."
Read that again, and let it sink in. One of the most powerful companies in the world is openly pledging to circumvent the abortion laws in its home state by pledging to help women travel elsewhere to get abortions on the companys dime. All in the name of ensuring that the killing of unborn babies continues unabated.
Eli Lilly has made quite the habit of going after kids. In one of the largest settlements in pharmaceutical-industry history, Eli Lilly had to pay out $1.42 billion after it pleaded guilty to pushing Zyprexa, an antipsychotic, for off-label uses in children and elderly dementia patients in 2009.
Eli Lilly is the second- or third-largest employer in Indianapolis with 10,400 employees working out of its headquarters there.
"As a global company headquartered in Indianapolis for more than 145 years, we work hard to retain and attract thousands of people who are important drivers of our states economy. Given this new law, we will be forced to plan for more employment growth outside our home state, the Eli Lilly statement went on to say.
To a certain extent, Eli Lillys shift away from its conservative home state of Indianapolis in favor of the blue coasts has been going on for some time. The pharmaceutical giant has research and development outfits in New York City, San Francisco, and San Diego. It also recently announced a $700 million building project for a genetic-medicine facility in Boston. Nevertheless, Eli Lillys willingness to throw away almost 150 years of history, and replace or force large swaths of their workforce to move in the name of making sure women can kill their unborn child in the womb is a testament to the corporate sectors left-wing radicalism.
For far too long, the conservative movement has been mystified at corporate Americas willingness to jump in bed with liberals. Liberals want to raise taxes and regulate the economy, conservatives thought. How could corporate America side with them? Initially, conservatives thought it was an aberration. Then conservatives started to talk about betrayal. But for a while, the strongest language we could muster in response was that these institutions have been hijacked by low-level millennials.
Surely, theres a bit of truth to the "hijacked" narrative. But the alliance between liberals and capital is much more fundamental. By encouraging the individual's pursuit of the unbounded self, liberalism severs the ties that bind individuals to people and place. Marriage, family, community, and nation must all be radically redefined as nothing more than non-binding contracts the individual defines for himself.
But man, Plato reminds us, is a being in search of meaning. Trying to purge these traditional institutions of meaning does not not rid us of our natural impulse to pursue it. Whats left, then, to provide meaning, if life is but a series of self-conceived nugatory contracts?
In these circumstances, capitalism has an answer. If life is nothing but a series of contracts, then at least you get monetarily compensated for selling your labor, which cant be said for arguably more difficult jobs, being a husband or a wife or a parent.
Subscribe Today Get weekly emails in your inbox
Corporate Americas support for abortion isnt just a matter of protecting its bottom line. Liberalism and capitalism are natural allies because both seek to free the individual from natural constraints, the former through rights, the latter through the pursuit of profit.
No surprise, Eli Lilly found some support from the Indianapolis Chamber of Commerce. "Over the last two weeks, the Indiana General Assembly has debated a substantial policy change on the issue of abortion in a compressed timeframe," a statement from the chamber said. "Such an expedited legislative process rushing to advance state policy on broad, complex issues is, at best, detrimental to Hoosiers, and at worst, reckless."
This isnt to say that conservatives shouldnt care about free and fair markets. Its the recognition that markets, like the rights that we enjoy while participating in them, are intermediate ends to a higher social goodthe flourishing of human society. And babies, dare I say, are pretty important to that mission.
Go here to read the rest:
Corporate America's Abortion Radicalism - The American Conservative
- CRISPR: A game-changing genetic engineering technique - January 4th, 2023
- Genetic Counseling Online Course - School of Medicine Columbia ... - January 4th, 2023
- Genetics & Medicine - Site Guide - NCBI - National Center for ... - December 27th, 2022
- Lilly, ProQR to expand genetic medicine development agreement - December 27th, 2022
- Central Dogma and Genetic Medicine - HHMI BioInteractive - November 24th, 2022
- Social, Environmental, Cognitive, and Genetic Influences on the Use of ... - November 24th, 2022
- Genetically modified food controversies - Wikipedia - October 29th, 2022
- BSGM - The British Society for Genetic Medicine - October 13th, 2022
- Genetic and Genomic Medicine - Nationwide Children's Hospital - October 13th, 2022
- Carrier Screening for Genetic Conditions | ACOG - October 13th, 2022
- New NHS genetic testing service could save thousands of children in England - The Guardian - October 13th, 2022
- Vertex, after setbacks, moves forward with second-generation rare disease drug - BioPharma Dive - October 13th, 2022
- Passage Bio Announces Appointment of William Chou, M.D. as Chief Executive Officer - Yahoo Finance - October 13th, 2022
- Metagenomi Announces Participation in October Investor and Industry Conferences - Business Wire - October 4th, 2022
- NovaSeq X machines will make genetic analysis even faster and cheaper - Mezha.Media - October 4th, 2022
- ORYZON to Give Updates on Corporate Progress in October - BioSpace - October 4th, 2022
- e-therapeutics: Fundraise of 13.5 million - BioSpace - October 4th, 2022
- The inheritance of hope curing genetic heart disease now within grasp - British Heart Foundation - October 4th, 2022
- MS Genetic Counseling | Ohio State College of Medicine - September 16th, 2022
- Genetic Counselor - Mayo Clinic College of Medicine & Science - September 16th, 2022
- UCLA researcher awarded National Academy of Medicine prize for work on genetics of autism - Newswise - September 16th, 2022
- Medical research doesn't serve everyone. This effort hopes to build one of the most diverse health databases ever - Colorado Public Radio - September 16th, 2022
- Precision Medicine Offers Hope for More Targeted Rash Diagnosis and Treatment - Dermatology Times - September 16th, 2022
- Redmond firefighters to 'Fill the Boot' for Muscular Dystrophy Association - KTVZ - September 16th, 2022
- Why Monkeypox Wasnt Another COVID-19 - FiveThirtyEight - September 16th, 2022
- Endometriosis Researchers One Step Closer to Diagnosing Condition With Menstrual Blood - Business Wire - September 16th, 2022
- The Biggest CGT Breakthroughs Through the Eyes of Our 2022 Power List - The Medicine Maker - September 16th, 2022
- Humans evolved with their microbiomes like genes, your gut microbes pass from one generation to the next - The Conversation - September 16th, 2022
- When to Use Targeted Therapy for Iodine-Refractory Thyroid Cancer - Targeted Oncology - September 16th, 2022
- Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - PR Newswire - September 16th, 2022
- CRISPR is 10: A decade of gene editing refinements presents new ways to address agricultural diseases thought to be incurable - Genetic Literacy... - September 16th, 2022
- Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for ... - The Bakersfield Californian - September 8th, 2022
- 'Record' Gains in Bringing Research Closer to the Patient - Applied Clinical Trials Online - September 8th, 2022
- Metagenomi Announces Participation in September Investor and Industry Conferences - Business Wire - September 8th, 2022
- Sarepta Therapeutics Announces That FDA has Lifted its Clinical Hold on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy - Yahoo Finance - September 8th, 2022
- Studies Reveal Aggressive Prostate Cancer Linked to Ancestral Heritage - DocWire News - September 8th, 2022
- Lonza and Touchlight collaboration will expands customer's access to DNA - Labiotech.eu - September 8th, 2022
- Genetic variants in miR-145 gene are associated with the risk of asthma in Taiwan | Scientific Reports - Nature.com - September 8th, 2022
- Elderly are more affected by COVID brain fog, but 'cognitive rehab' could be an effective treatment - Genetic Literacy Project - September 8th, 2022
- A therapy found to improve cognitive function in patients with Down syndrome - EurekAlert - September 8th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 30th, 2022
- Morris Animal Foundation Golden Retriever Lifetime Study Celebrates 10 Years - PR Newswire - August 30th, 2022
- Immortal jellyfish genes identified that may explain their long lives - New Scientist - August 30th, 2022
- Walk Again Or Stop Blindness. How Gene Therapy Is Revolutionizing Medicine - Nation World News - August 30th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 30th, 2022
- Therapeutic Effects of Tretinoin | JIR - Dove Medical Press - August 30th, 2022
- Physical Activity May Have a Stronger Role than Genes in Longevity - Newswise - August 30th, 2022
- BridgeBio, Baylor College of Medicine to Collaborate on Genetic Disease ... - August 22nd, 2022
- New $2.8-million gene therapy becomes most expensive medicine in history - New Atlas - August 22nd, 2022
- Molecular Map Reveals Insights Into the Genetic Drivers of CLL - The ASCO Post - August 22nd, 2022
- Biopharmaceutical Company Expands Clinical Trials On Texas A&M-Developed Angelman Syndrome Treatment - Texas A&M University Today - August 22nd, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo News - August 22nd, 2022
- Marketing and Industry Trends Influencing Precision Medicine in 2022 - Healthcare Tech Outlook - August 22nd, 2022
- expert reaction to study investigating use of genetic risk score for prostate cancer in men with lower urinary tract symptoms to predict diagnosis -... - August 22nd, 2022
- As the Smithsonian wraps a genome exhibit, leaders in the field reflect - STAT - August 22nd, 2022
- Why some people suffer more from COVID-19 than others - EurekAlert - August 22nd, 2022
- Q3 2022 Earnings Forecast for LogicBio Therapeutics, Inc. Issued By William Blair (NASDAQ:LOGC) - Defense World - August 22nd, 2022
- Next generation patient avatars: Expanding the possibilities with MicroOrganospheres - EurekAlert - August 22nd, 2022
- Masters Program in Genetic Counseling - Perelman School of Medicine at ... - August 14th, 2022
- Admissions | Master's Program in Human Genetics & Genetic Counseling ... - August 14th, 2022
- The Silver Lining Of Innovation in Genetic Medicine - Pharmaceutical Executive - August 14th, 2022
- Genetics Team Serves as Go-to for Mom of Son With Extremely Rare Disorder - Stanford Medicine Children's Health Blog - Stanford Children's Health - August 14th, 2022
- UI professor receives grant from National Institutes of Health - Iowa Now - August 14th, 2022
- Lilly's Taltz (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce Injection Site Pain for Improved Patient Experience - PR Newswire - August 14th, 2022
- Research Roundup: 21 Genes Linked to Increased Risk of Alzheimer's and More - BioSpace - August 14th, 2022
- Personalised medicine made in hospitals can revolutionise the way diseases are treated the challenge now will be implementing it - The Conversation... - August 14th, 2022
- Beyond Paxlovid for covid-19: The hunt for better covid medications - Grid - August 14th, 2022
- PVM to Play Role in Research on New Patent-pending Method to Mass-produce Antitumor Cells to Treat Blood Diseases and Cancer - Purdue University - August 14th, 2022
- Analyzing Kiromic BioPharma (NASDAQ:KRBP) and LogicBio Therapeutics (NASDAQ:LOGC) - Defense World - August 14th, 2022
- A team of Oxford and Mexican researchers want to diversify genomic databases. Can they end 'parachute science,' too? - STAT - August 14th, 2022
- The aging heart accumulates mutations while losing the ability to repair them - EurekAlert - August 14th, 2022
- Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results - GuruFocus.com - August 5th, 2022
- Population Genetic Testing: Save Lives And Money, While Avoiding Financial Toxicity - Forbes - August 5th, 2022
- Genetic Counselors Scramble Post- Roe to Provide Routine Pregnancy Services without Being Accused of a Crime - Scientific American - August 5th, 2022
- GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.com - August 5th, 2022
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results - Yahoo Finance - August 5th, 2022
- Researchers discover one of the largest known bacteria-to-animal gene transfer inside a fruit fly - EurekAlert - August 5th, 2022
- Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Yahoo Finance - August 5th, 2022
- Medical Student's Crime In Cipolletti: They Found A Man's DNA Under The Victim's Thumb - Nation World News - August 5th, 2022
- A new era: After winding path and safety scares, gene therapy enters the clinic - Sydney Morning Herald - August 5th, 2022